A Phase Ⅰ/Ⅱ, Open-Label, Multicenter Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of GB261 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

  • Inam, Shafqat (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date12/05/23 → 11/05/25

Keywords

  • Clinical Trials
  • Non-hodgkin lymphoma
  • Chronic Lymphocytic Leukemia

Clinical Trial Phase

  • Phase I
  • Phase II